MedPath

Effect of Kushmanda Avaleha in Slow learners as a memory enhancer

Phase 4
Completed
Registration Number
CTRI/2022/10/046675
Lead Sponsor
Yenepoya Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
172
Inclusion Criteria

1. Children admitted in the school of age group 10 to16 years of either sex

2.Children screened as slow learners as per IQ test.

3.consistent academic underperformance – last 2 year or more years.

4.Consenting parents

5.Individuals who comes under IQ level 75 - 90 range

Exclusion Criteria

1.Any past or present psychotic symptoms

2.IQ below 75(mentally retarded or subnormal children)

3.Past head injury warranting hospitalization

Any major medical illness, Uncorrectable sensory handicap

4.Congenital anomalies like Down syndrome

Current antiepileptic medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Memory and IQ level will be assessed <br/ ><br>2. after 90 days course study will be overTimepoint: 12 weeks
Secondary Outcome Measures
NameTimeMethod
• Study can be done more than 12 weeks, its like a remedial measures for slow learners.Timepoint: 24 weeks
© Copyright 2025. All Rights Reserved by MedPath